BlackRock Japan’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

BlackRock Japan’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,265	Closed	-$21K	–	1529
2016 Q1	$21K	Buy	2,265 +432	+24%	+$4.65K	﹤0.01%	1182
2015 Q4	$27K	Hold	1,833	–	–	﹤0.01%	1125
2015 Q3	$30K	Sell	1,833 -54	-3%	-$1.1K	﹤0.01%	1052
2015 Q2	$43K	Buy	+1,887	New	+$37.6K	﹤0.01%	1098
2014 Q4	–	Sell	-6,692	Closed	-$76K	–	1397
2014 Q3	$76K	Sell	6,692 -540	-7%	-$6.16K	﹤0.01%	994
2014 Q2	$87K	Buy	7,232 +168	+2%	+$1.98K	﹤0.01%	960
2014 Q1	$82K	Buy	+7,064	New	+$120K	﹤0.01%	1094

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's MNTA Position: Q2 2016 in Review

BlackRock Japan sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2016, closing a stake of 2,265 shares — an estimated $21K sold.

BlackRock Japan first reported a position in MNTA in Q1 2014 and held it in 7 quarters. The position peaked at $87K in Q2 2014. 146 funds tracked by Wall St. Rank hold MNTA as of Q2 2016.

BlackRock Japan reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
BlackRock Japan sold 2,265 Momenta Pharmaceuticals, Inc. shares in Q2 2016, an estimated $21K.
BlackRock Japan first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 7 quarters.
BlackRock Japan's Momenta Pharmaceuticals, Inc. position peaked at $87K in Q2 2014.
146 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2016.

Based on BlackRock Japan's 13F filing for Q2 2016, filed 10 Aug 2016.